ClinicalTrials.gg
RecruitingNCT06109363Updated Jun 24, 2026

A Stepped Care Model to Deliver CBT-I in Community

An interventional study of Cognitive behavioral therapy for insomnia (CBT-I) in Insomnia and Sleep Disturbance, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,100
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong — 14 open to participants now, 14 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Chinese University of Hong Kong.

Planned enrollment
Largest of 25
1,100 · median 80
Started
2023
with 3 others
No phase
24 of 25
13 open now
Primary completion
2026-10
later than 5 of 13 live
Registered
13th of 25
by date

Among the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, this one has the largest planned enrollment, is one of 4 that started in 2023, is one of 24 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 13th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

14 of the 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Sleep Initiation and Maintenance Disorders by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Insomnia is one of the most common sleep disorders and affects approximately 10 - 40% of the population across different age groups in Hong Kong. Cognitive behavioral therapy for insomnia (CBT-I) is the first line treatment for adult insomnia due to its comparable effect to medication in short term but is more sustainable in the long run. However, only a few sufferers have received CBT-I, due to limited accessibility, lack of trained sleep therapists, time costing and geographical limitations. To increase CBT-I accessibility, different formats of CBT-I have been proposed. Empirical evidence including ours consistently suggested that self-help digital CBT-I is effective in improving sleep while its augmentation with a guided approach could further enhance the treatment gain. Previous evidence has suggested that although self-help CBT-I could lead to positive outcomes, the drop out rate is quite high and maybe less effective for patients with comorbidity or high level of distress.

Thus, a stepped-care approach to CBT-I that utilizes online self help and therapist-guided modes of delivery might be a potential way to facilitate efficient dissemination of effective insomnia treatment resources. The effectiveness of the stepped care model will be evaluated in a real world setting using stepped-wedge cluster randomized controlled design. The program will be rolled out to different districts in Hong Kong sequentially in 18 districts over 4 steps with a eqaully spaced time periods.

Read the detailed description

This interventional study will be a multicenter, assessor-blinded, pragmatic stepped-wedge cluster randomized controlled trial. A total of 18 districts will be included in the study and the randomization will be carried out based on the districts. The stepped-care CBT-I intervention will be sequentially rolled out to the 4-6 districts per step according to a computer-generated random number while the remaining clusters will continue to stay unexposed to the CBT-I intervention over the control period. Therefore after 4-step exposure, all clusters will receive the stepped-care CBT-I intervention. A total of 3 follow-up assessments (post intervention, 3-month and 12-month follow up) will be conducted to assess the effectiveness and long-term effects of the stepped care model.

03

Conditions studied

  • Insomnia
  • Sleep Disturbance

Keywords

  • Insomnia
  • Stepped care model
  • Stepped wedge cluster randomized trial
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Chinese adults aged 18-70 years old,
  2. The score of Insomnia Severity Index ≥ 10.

Exclusion criteria

Exclusion Criteria:

  1. present with psychotic disorders such as bipolar disorder and schizophrenia,
  2. present with severe depression or suicidal ideation,
  3. present with neurodegenerative diseases that prevent participant from completing the intervention (e.g., dementia and Parkinson's disease).
  4. unable to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
1,100 participants (estimated)

Study arms

  • Experimental
    Stepped-care CBT-I group

    A total of 3 steps of CBT-I intervention will be provided, with the objectives to increase the awareness of sleep health, increase sleep literacy, establish good sleep hygiene and treat insomnia. Step 1: self-help digital CBT-I program; Step 2: guided CBT-I program; Step 3: individualized consultation.

    Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)

  • No intervention
    Control group

    Participants in the control group remain unexposed to the stepped-care CBT-I intervention.

Interventions

  • BehavioralCognitive behavioral therapy for insomnia (CBT-I)

    CBT-I intervention will be provided to participants once their districts are exposed.

06

What researchers measure

Primary outcomes

  1. Insomnia severity index

    The primary outcome will be the perceived insomnia severity measured by Insomnia Severity Index (ISI).

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

Secondary outcomes

  1. Severity of depression

    Patient Health Questionnaire-9 (PHQ-9) will be used to measure the severity of depression.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  2. Severity of anxiety

    General Anxiety Disorder-7 (GAD-7) will be used to measure the severity of anxiety.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  3. Health-related quality of life

    The health-related quality of life (HRQoL) will be measured by the EuroQol-5D (EQ).

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  4. Chronic insomnia diagnosis

    A checklist based on Diagnostic and statistical manual of mental disorders will be implemented to measure the incidence of chronic insomnia.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  5. Medication usage

    A checklist will be used to measure the subject's medication usage change over the past 3 months.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  6. Clinical global impression

    Clinical Global Impression (CGI) will be used to assess the overall improvement or change in a patient's condition over time.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  7. Patient-report clinical global impression

    A single-item CGI will be used to ask the participant whether they experience sleep improvement or change over the past week or not.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  8. Sleep duration

    Two self-report questions will be used to record the sleep duration during weekdays and weekends of the participants.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  9. Subjective sleep as measured by sleep diary

    Self-report sleep diary will be used to record subjective sleep of the participants including total time in bed, sleep onset latency, total sleep duration, sleep efficiency and wake after sleep onset.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  10. Healthcare resource use

    The use and expense of sleep-promoting medication, psychotherapy, and other complementary treatments for sleep improvement over the past 3 months will be collected from individual participants using a self-developed questionnaire, with a focus on their healthcare resource utilization.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

  11. Work and social functioning

    A 5-item questionnaire developed from Work and Social Adjustment Scale (WSAS) will be used to measure the daytime functioning of the participants such as ability to work, home management, social and private leisure activities, and close relationship maintenance.

    Time frame: Post-intervention (ranging from 8 weeks to 24 weeks, depending on the treatment level), 3-month post-intervention and 12-month post-intervention follow up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Oct 2026, 35 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 35 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2023
First posted
Oct 31, 2023
StartActual
Oct 23, 2023
Primary completionEst.
Oct 22, 2026
CompletionEst.
Apr 22, 2027
Last update
Jun 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06109363
Responsible party
Professor Wing Yun Kwok (Professor, Department of Psychiatry, Chinese University of Hong Kong) — Principal investigator
First posted
Oct 31, 2023
Start date
Oct 23, 2023
Primary completion
Oct 22, 2026 (estimated)
Completion
Apr 22, 2027 (estimated)
Last update
Jun 24, 2026

Study contacts

Rachel Ngan Yin Chan, PhD
Contact
rachel.chan@cuhk.edu.hk
39710548
Jucheng Yu, PhD
Contact
juchengyu@cuhk.edu.hk
39710548
Yun Kwok Wing, FRCPsych
principal investigator · Department of Psychiatry, the Chinese University of Hong Kong

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion